RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

ROP

Roper Technologies, Inc.

66
Fundamentals66/ 100
Valuation61/ 100
Upside potential46/ 100
Risk potential15/ 100

ROP has the edge over RKLB overall, supported by lower modeled downside and stronger valuation.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

ROP Fundamentals

MetricStatus
Stable
Strong
Strong
Stable

ROP's profitability and cash flow are currently strong, and its revenue and balance sheet are stable.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

ROP PE Valuation

CHEAPFAIREXPENSIVE13x27x40x54x
CHEAPFAIREXPENSIVE13x27x40x54x
LevelPEPriceVs current
Cheap17x$423-11%
Current19x$478—
Forward20x$478—
Fair28x$720+51%
Expensive42x$1,073+124%

Historical ranges are pointers, not guarantees.

ROP's PE is in its cheap range at 19x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 20x.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

ROP Forward outlook

MetricOutlook
Stable
Growth
Growth
Improving
Limited
High

Analysts expect earnings and revenue growth for ROP, with profitability improving.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB has a better modeled risk to reward balance than ROP, with more potential upside relative to its potential downside.

ROP Risk to reward

ScenarioChangePrice
Upside+13%$540.63
Downside-15%$404.44

Calculated from the latest close: $477.87 on Nov 12.

ROP trails RKLB on modeled risk to reward, with less potential upside relative to its potential downside.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.

ROP Earnings Per Share

Q4 2023: $12.89Q1 2024: $13.78Q2 2024: $13.50Q3 2024: $13.67Q4 2024: $14.34Q1 2025: $13.86Q2 2025: $14.23Q3 2025: $14.51Q4 2025: $14.20Q1 2026: $16.01Q2 2026: $24.14Q3 2026: $25.34Forward: $24.21
Q4 2023: $12.89Q1 2024: $13.78Q2 2024: $13.50Q3 2024: $13.67Q4 2024: $14.34Q1 2025: $13.86Q2 2025: $14.23Q3 2025: $14.51Q4 2025: $14.20Q1 2026: $16.01Q2 2026: $24.14Q3 2026: $25.34Forward: $24.21
QuarterTTM EPSYoY
Forward$24.21-4.5%
Q3 2026$25.34+75%
Q2 2026$24.14+70%
Q1 2026$16.01+16%
Q4 2025$14.20-1%
Q3 2025$14.51+6.1%
Q2 2025$14.23+5.4%
Q1 2025$13.86+0.6%
Q4 2024$14.34+11%

ROP has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over ROP on sales, with stronger typical year-over-year growth.

ROP Quarterly Revenue

Q4 2023: $1.6BQ1 2024: $1.7BQ2 2024: $1.7BQ3 2024: $1.8BQ4 2024: $1.9BQ1 2025: $1.9BQ2 2025: $1.9BQ3 2025: $2BQ4 2025: $2.1BQ1 2026: $2.1BQ2 2026: $2.1BQ3 2026: $2.2B
Q4 2023: $1.6BQ1 2024: $1.7BQ2 2024: $1.7BQ3 2024: $1.8BQ4 2024: $1.9BQ1 2025: $1.9BQ2 2025: $1.9BQ3 2025: $2BQ4 2025: $2.1BQ1 2026: $2.1BQ2 2026: $2.1BQ3 2026: $2.2B
QuarterRevenueYoY
Q3 2026$2.2B+7.6%
Q2 2026$2.1B+8.5%
Q1 2026$2.1B+11%
Q4 2025$2.1B+9.7%
Q3 2025$2B+14%
Q2 2025$1.9B+13%
Q1 2025$1.9B+12%
Q4 2024$1.9B+16%

ROP's revenue has grown year over year for 14 quarters in a row: $2.2B last quarter, up 7.6% from the same quarter a year ago.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

ROP Free Cash Flow

Q4 2023: $622MQ1 2024: $532MQ2 2024: $384MQ3 2024: $755MQ4 2024: $722MQ1 2025: $529MQ2 2025: $404MQ3 2025: $870MQ4 2025: $738MQ1 2026: $592MQ2 2026: $470MQ3 2026: $821M
Q4 2023: $622MQ1 2024: $532MQ2 2024: $384MQ3 2024: $755MQ4 2024: $722MQ1 2025: $529MQ2 2025: $404MQ3 2025: $870MQ4 2025: $738MQ1 2026: $592MQ2 2026: $470MQ3 2026: $821M
QuarterFree cash flowYoY
Q3 2026$820.6M-5.6%
Q2 2026$469.5M+16%
Q1 2026$592.1M+12%
Q4 2025$738M+2.2%
Q3 2025$869.5M+15%
Q2 2025$404.1M+5.2%
Q1 2025$528.7M-0.5%
Q4 2024$722.2M+16%

ROP has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

ROP Total Shares

Q4 2023: 107MQ1 2024: 108MQ2 2024: 108MQ3 2024: 108MQ4 2024: 108MQ1 2025: 108MQ2 2025: 108MQ3 2025: 108MQ4 2025: 108MQ1 2026: 105MQ2 2026: 101MQ3 2026: 99M
Q4 2023: 107MQ1 2024: 108MQ2 2024: 108MQ3 2024: 108MQ4 2024: 108MQ1 2025: 108MQ2 2025: 108MQ3 2025: 108MQ4 2025: 108MQ1 2026: 105MQ2 2026: 101MQ3 2026: 99M
PeriodChange %Net change
Quarterly-1.2%-1.2M shares
1 year-8.3%-9M shares
3 years-7.6%-8.2M shares
5 years-6.8%-7.3M shares
Available history-5.4%-5.7M shares

ROP has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ROP Net Leverage

Q4 2023: 2.5xQ1 2024: 2.9xQ2 2024: 2.7xQ3 2024: 3.0xQ4 2024: 2.7xQ1 2025: 2.5xQ2 2025: 2.9xQ3 2025: 3.0xQ4 2025: 2.9xQ1 2026: 3.2xQ2 2026: 3.4xQ3 2026: 2.9x
Q4 2023: 2.5xQ1 2024: 2.9xQ2 2024: 2.7xQ3 2024: 3.0xQ4 2024: 2.7xQ1 2025: 2.5xQ2 2025: 2.9xQ3 2025: 3.0xQ4 2025: 2.9xQ1 2026: 3.2xQ2 2026: 3.4xQ3 2026: 2.9x
QuarterNet LeverageStatus
Q3 20262.9xModerate
Q2 20263.4xElevated
Q1 20263.2xElevated
Q4 20252.9xModerate
Q3 20253.0xModerate
Q2 20252.9xModerate
Q1 20252.5xModerate
Q4 20242.7xModerate

ROP's net debt is about 2.9 years of its operating earnings (EBITDA), about the same as a year ago.

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

ROP Weekly Momentum

MetricValueStatus
RSI70.3Overbought
Stochastic86.5Overbought

ROP's weekly RSI is 70 (overbought) and its Stochastic is 87 (overbought).

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

ROP PE vs Industrials Sector

MetricROPSector medianRelative
PE19x24x22% below
PE %285830 pts below

ROP is trading at 19x earnings, a 22% discount to the Industrials sector's median of 24x, though its recent earnings include one-off gains.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.

ROP Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$414.915% above
20 week MA$398.520% above
50 week MA$380.726% above
100 week MA$458.44.2% above
200 week MA$484.81.4% below

ROP has the edge over RKLB on trend strength, trading above more of its moving averages.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.

ROP Yearly ROI

YearStart priceEnd priceROI
2020$357.3$420.1+18%
2021$420.1$478.3+14%
2022$478.3$430.1-10%
2023$430.1$545.2+27%
2024$545.2$523.9-3.9%
2025$523.9$450.8-14%
2026 YTD$450.8$477.9+6%

ROP has the edge over RKLB on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key